Home Study Details

    Program Type

    Home Study Webcast


    1.5 Contact Hour(s)

    Release Date

    Sunday, January 6, 2019

    Offline Date

    Friday, January 7, 2022

    ACPE Expiration Date

    Friday, January 7, 2022

    Target Audience




    • Overview

      This session is part of the Pain Management Specialty Pharmacist series. It explores the effective management of pain within the context of the current opioid crisis. This session seeks to summarize the best practices in pain management regarding patient education, treatment selection, adherence, and diversion monitoring. The role of urine drug screening and the incorporation of naloxone into is discussed. DEA “Red Flags” for prescribers and dispensers are functionally explored with an emphasis on how to respectfully proceed when misuse, abuse, or diversion is suspected.


      • Slide Document :   18293H01_4pp.pdf
      • Slide Document :   18293H01_2pp.pdf

      Financial Support By

    • Pharmacist

      Distinguish urine drug screening (UDS) from urine drug testing (UDT) and identify appropriate recommendations as to how to conduct either in a patient care practice.
      Identify appropriate, succinct, and comprehensive patient education on naloxone.
      Recall the "DEA Red Flags" for prescribers and dispensers, and explain how to respectfully proceed when misuse, abuse, or diversion is suspected.
      Recall the best practices in pain management in regards to patient education, treatment selection, and adherence and diversion monitoring.
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-18-293-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).